As the Colorado General Assembly convenes for its 75th regular session on Wednesday, the American Cancer Society Cancer Action Network (ACS CAN) and its team of advocates is calling on legislators to support several priorities to improve the prevention, early detection and treatment of cancer.
The Denver City Council voted 11-1 Monday evening to end the sale of most flavored tobacco products within city limits. While the American Cancer Society Cancer Action Network (ACS CAN) and its team of advocates, including cancer survivors and patients, are encouraged by the decision, the legislation includes an exemption for flavored hookah tobacco products which ACS CAN does not support.
Lt. Governor Dianne Primavera received the National Distinguished Advocacy Award Wednesday morning in Washington, D.C., the most prestigious award presented by the American Cancer Society Cancer Action Network (ACS CAN), in recognition of her significant contribution in the fight against cancer.
Governor Jared Polis signed SB24-124 into law during a ceremony at the Governor’s Mansion on Monday afternoon, ensuring more Colorado patients with private insurance have coverage for biomarker testing. The American Cancer Society Cancer Action Network (ACS CAN) recognizes the signing of the bill as a positive first step to increasing access to biomarker testing to connect patients with the right treatment at the right time. During Monday’s ceremony, Governor Polis was surrounded by advocates from ACS CAN including cancer survivors, as well as bill sponsors Sen. Dafna Michaelson Jenet, Rep. Anthony Hartsook, and Rep. Monica Duran.
The American Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now complete, the bill now awaits the signature of Governor Jared Polis. If enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing.
DENVER, COLO. — MARCH 13, 2024 — American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Colorado convened at the State Capitol on Wednesday. They urged lawmakers to pass SB 124, which if enacted would ensure biomarker testing is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.
The American Cancer Society Cancer Action Network (ACS CAN) hosted its 15th annual Colorado Policy Forum at the University of Colorado Cancer Center, Wednesday evening. Leaders from the public health, business, education, and government sectors gathered learn about the work being done to try to end cancer in the state.
Attorneys General for six states and DC today announced a $462 million multi-state settlement to be paid out by JUUL Labs, following an investigation into its underage marketing practices to attract youth to its addictive e-cigarettes.
The American Cancer Society Cancer Action Network (ACS CAN) hosted ‘Cancer Action Day’ at the Colorado state capitol Wednesday. ACS CAN volunteers, including cancer survivors, patients, and caregivers met with several lawmakers and urged them to support and pass House Bill 1110, Healthcare Coverage for Biomarkers Testing. The bi-partisan legislation would expand equitable access to biomarker testing statewide.